Mailbox vs Active U.S. FDA Agent: What Foreign Manufacturers Should Require in 2026

Foreign food, drug, and device establishments that register with FDA generally must name a U.S. Agent. Most of them pick the cheapest listing they can find, paste a U.S. address into the form, and move on. What they have often bought is a forwarding address with a fee attached to it. FDA's regulations are unusually blunt about that arrangement: a U.S. Agent may not be a mailbox, an answering machine or service, or any other place where the person acting as your agent is not physically present. The words are in the rule, not in a guidance footnote.

This post is about that one distinction. It is not about whether you need an Agent at all, or how the Agent relates to facility registration. We covered that decision tree in U.S. FDA Agent vs Facility Registration: What Foreign Manufacturers Mix Up in 2026, and the full exporter briefing on what an Agent is for sits in What foreign exporters must know about a U.S. FDA Agent in 2026. Read those if the role itself is new to you. This one assumes you already know you need an Agent and asks a narrower question: what kind.

What the regulations actually say about physical presence

The food rule defines a U.S. Agent as a person residing or maintaining a place of business in the United States whom a foreign facility designates as its agent, and then adds the sentence that matters here: a U.S. Agent may not be in the form of a mailbox, answering machine or service, or other place where an individual acting as the foreign facility's agent is not physically present (21 CFR 1.227).

The drug establishment rule uses almost identical words. The United States agent must reside or maintain a place of business in the United States and may not be a mailbox, answering machine or service, or other place where a person acting as the United States agent is not physically present (21 CFR 207.69(b)). The device establishment rule is shorter but points the same way: the United States agent must reside or maintain a place of business in the United States, assist FDA in communications with the foreign establishment, respond to questions about its imported products and assist FDA in scheduling inspections (21 CFR 807.40).

Notice what the exclusion targets. It does not say the Agent must be an individual rather than a company; FDA's food facility registration Q&A confirms an Agent can be an individual, partnership, corporation or association. It does not require a particular office size or a particular state. What it rules out is the arrangement where the address exists but the person does not: a registered-agent mail drop, a virtual office, a call-answering service reading from a script, a "compliance portal" that is a web form with nobody behind it during U.S. business hours. FDA wants a human it can reach, at a real place of business, who will act for the facility when contacted.

The reason becomes obvious when you read the rest of the definition. The same rule says FDA will treat representations by the U.S. Agent as those of the foreign facility, and will consider information or documents provided to the U.S. Agent the equivalent of providing them to the foreign facility. The drug rule says the same thing in its own words: if FDA cannot reach the foreign registrant directly, providing information or documents to the United States agent is equivalent to providing them to the registrant. In plain terms, a notice delivered to your Agent is a notice delivered to you, whether or not anyone forwards it. That is why a mailbox is a liability rather than a convenience.

What an Agent is for: routine and emergency communications

The food rule describes the U.S. Agent as the communications link between FDA and the foreign facility for both emergency and routine communications, and says the Agent is the person FDA will contact when an emergency occurs unless the registration names a different emergency contact (21 CFR 1.227). The drug rule is more specific about the workload. The United States agent's responsibilities include reviewing, disseminating, routing and responding to all communications from FDA including emergency communications; responding to questions concerning the drugs that are imported or offered for import; and assisting FDA in scheduling inspections (21 CFR 207.69(b)).

Read that list as a job description and the mailbox model fails every line. Reviewing a communication means someone reads it the day it arrives and understands what it asks for. Routing it means knowing who at your plant owns the answer. Responding to questions about imported product means the Agent knows what you ship, under which registration and listing numbers, and can say so when an FDA investigator or an import district calls. Assisting with inspection scheduling means the Agent can put a proposed date in front of your quality head that week, not after the next mail-forwarding batch.

FDA's own Q&A on food facility registration puts it simply: the Agent must be able to serve as the communication link between FDA and the foreign facility, and must know whom to contact at the facility if an emergency arises. Nobody drafting those words was describing a PO box.

Passive versus active: where the difference shows up

Foreign manufacturers rarely see the gap on the day they appoint an Agent. They see it months later, in one of four places.

The confirmation step at registration

For food facilities, FDA verifies that the person named as U.S. Agent has actually agreed to serve, and will not confirm the registration or issue a registration number until that person confirms (21 CFR 1.231). An active Agent watches for that verification email and answers it the same day. A passive one lets it sit in a shared inbox, and your registration sits unconfirmed with it. The Q&A guidance says naming the Agent in the registration is enough to authorize them, provided the Agent has agreed to serve. The agreement is the point; the listing is just the record of it.

Keeping the registration aligned with reality

Your registration must carry the Agent's name, full address, phone number and email address (21 CFR 1.232), and you must update the registration within 60 calendar days of any change, including a change of U.S. Agent (21 CFR 1.234). A passive provider that quietly moves address, changes its phone number or reorganizes which entity holds your appointment can leave your registration stale without you knowing. An active Agent treats its own contact details in your registration as something it is accountable for, and tells you before anything changes.

Notices with clocks on them

Import alerts, detention notices, requests for records, inspection scheduling requests, notices that a listing or registration is deficient: each arrives with an expectation of a response inside days, sometimes hours. Under the rules quoted above, delivery to the Agent is delivery to you. A forwarding service that batches mail weekly, or an answering service that logs a message and emails it to a general address, has already consumed most of your response window before you know a clock is running.

Inspections

When FDA plans to inspect a foreign facility, the Agent is one of the channels through which scheduling happens. An active Agent already knows your plant's site contact, your language needs, your production calendar and which products are shipped to the U.S., so the exchange with FDA is short. A passive Agent forwards a message and waits.

None of this requires the Agent to be a regulatory expert in your product category, although it helps. It requires the Agent to be present, reachable and informed about your facility. That is the whole test.

Red flags when you are shopping for an Agent

You will not find "mailbox" in any provider's marketing. You find it in what they cannot show you. Before you sign, ask for the following and treat a hedge as a no.

A physical place of business, with a person in it. Ask for the street address that will appear in your registration and ask who works there. A suite number at a registered-agent address, a co-working mailbox or a "U.S. presence" that resolves to a mail-handling company is exactly what 21 CFR 1.227 and 207.69 exclude. If the address is not somewhere a person could sit and take FDA's call, keep looking.

A named individual and a direct line. You should know the name of the person FDA will reach, their direct phone number and their email, and they should be the same details that go into your registration. A generic "compliance@" inbox and a switchboard number are not an Agent, they are a queue.

A stated response time for FDA correspondence. Ask, in writing, how quickly the provider will read and forward an FDA communication and how you will be notified. The answer should be measured in hours, with a named backup for when the primary person is unavailable. If the provider will not commit to a time, they are telling you what kind of Agent they are.

Familiarity with the FDA systems your registration lives in. For food facilities, that is the Food Facility Registration Module inside FDA's Unified Registration and Listing Systems; for drug establishments, it is establishment registration and drug listing through SPL submissions to CDER Direct or the Electronic Submissions Gateway. Ask whether the Agent will handle the U.S. Agent confirmation step itself and whether it can support your renewals inside those systems. An Agent that has never logged into FURLS will not notice when your registration is about to lapse.

Fee-only relationships. Some listings sell the appointment as a line item with nothing behind it: pay the annual fee, receive a letter, hear nothing until next year's invoice. The fee is not the problem. A single fee per facility per year is a perfectly normal way to price the role. The problem is when the fee buys a name on a form and no one who will act on your behalf when FDA writes.

No knowledge of what you ship. If the provider has not asked what products you make, which are shipped to the U.S., and who at your plant owns quality and regulatory, it cannot answer the questions 21 CFR 207.69 says it must be able to answer. The onboarding conversation tells you a great deal about the next twelve months.

How this differs from the "Agent versus registration" question

People sometimes read a post like this and conclude that appointing an active Agent takes care of registration. It does not. Registration is a filing about your site; the U.S. Agent is a person named inside it. You need both, and the order and the product-by-product logic are laid out in the Post 1 decision tree linked above. The point of this post is narrower: once you have decided who fills the Agent line in that filing, the regulations tell you what that person must be, and a mailbox does not qualify.

Appointing an active U.S. Agent in Albuquerque

Axentra Global Pharma Compliance LLC acts as U.S. Agent for foreign food, dietary supplement, cosmetic, drug and device facilities from a real place of business at 1209 Mountain Road Pl NE, Suite N, Albuquerque, NM 87110. The appointment is handled by a named regulatory professional with a direct line, not a shared inbox, and FDA correspondence is read and routed to your facility the day it arrives, with 24/7 handling for anything marked urgent. The U.S. Agent and facility registration bundle starts at $299 per year per facility for food, dietary supplement and cosmetic sites; drug and device facilities are quoted on scope because of the establishment fee and listing work involved.

If you already hold a confirmed registration and only need to replace a passive Agent, we can take over the appointment and help you update the U.S. Agent details with FDA (foreign facilities generally must update registration changes within 60 calendar days under 21 CFR 1.234). If you have not registered yet, we file the registration alongside the appointment.

Appoint an active U.S. Agent: U.S. FDA Agent Services for Foreign Manufacturers. If your facility still needs its FDA registration filed or renewed, see FDA facility registration. Call +1 505 358 4858 or email info@axentracompliance.com.